ARQT

26.3602.98%
LV

Latha Vairavan

Senior VP & Chief Financial Officer

Ms. Latha Vairavan serves as Senior VP & Chief Financial Officer of Arcutis Biotherapeutics, Inc. from 2025. Ms. Vairavan was Vice President of Finance of Arcutis Biotherapeutics, Inc until 2025 and also served as its Corporate Controller since November 2024 until 2025. She served as Vice President of Investor Relations at Arcutis Biotherapeutics, Inc until November 2024. where she is responsible for all investor relations activities as well as overseeing financial planning and consolidation of revenue, gross-to-net and expenses for all functions. She joined the company as executive director, financial planning and analysis in 2020. Previously, She was at Amgen for many years, where she held various roles of increasing responsibility within the finance organization, culminating as finance director for US value and access, where she modeled the impact of reimbursement policy changes and liaised with state government affairs teams on various state related drug pricing requirements. She started her career as a financial consultant working for KPMG and Arthur Andersen. She holds a BS in Business Administration, Finance, from the University of Southern California and is a licensed CPA in California.

Positions